Aerovate Therapeutics Inc
NASDAQ:AVTE

Watchlist Manager
Aerovate Therapeutics Inc Logo
Aerovate Therapeutics Inc
NASDAQ:AVTE
Watchlist
Price: 2.53 USD Market Closed
Market Cap: 73m USD
Have any thoughts about
Aerovate Therapeutics Inc?
Write Note

Income Statement

Earnings Waterfall
Aerovate Therapeutics Inc

Revenue
0 USD
Operating Expenses
-90.3m USD
Operating Income
-90.3m USD
Other Expenses
5.6m USD
Net Income
-84.6m USD

Income Statement
Aerovate Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(9)
(11)
(15)
(18)
(23)
(31)
(38)
(46)
(53)
(60)
(68)
(75)
(81)
(88)
(94)
(90)
Selling, General & Administrative
(1)
(1)
(3)
(5)
(8)
(11)
(14)
(14)
(15)
(15)
(15)
(17)
(17)
(18)
(18)
(21)
Research & Development
(8)
(9)
(12)
(13)
(15)
(20)
(24)
(31)
(39)
(45)
(53)
(59)
(64)
(71)
(76)
(69)
Operating Income
(9)
N/A
(11)
-23%
(15)
-33%
(18)
-27%
(23)
-25%
(31)
-36%
(38)
-21%
(46)
-21%
(53)
-17%
(60)
-12%
(68)
-14%
(75)
-11%
(81)
-8%
(88)
-9%
(94)
-7%
(90)
+4%
Pre-Tax Income
Interest Income Expense
(0)
(0)
0
0
0
0
0
1
2
3
4
5
6
6
6
6
Total Other Income
(1)
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Pre-Tax Income
(10)
N/A
(11)
-14%
(15)
-33%
(18)
-27%
(23)
-25%
(31)
-35%
(37)
-20%
(45)
-20%
(51)
-15%
(57)
-11%
(64)
-12%
(70)
-9%
(75)
-8%
(82)
-9%
(88)
-7%
(85)
+4%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
Income from Continuing Operations
(10)
(11)
(15)
(18)
(23)
(31)
(37)
(45)
(52)
(57)
(64)
(70)
(76)
(82)
(88)
(85)
Net Income (Common)
(10)
N/A
(11)
-14%
(15)
-32%
(19)
-26%
(23)
-24%
(31)
-35%
(37)
-20%
(45)
-20%
(52)
-15%
(57)
-11%
(64)
-12%
(70)
-9%
(76)
-8%
(82)
-9%
(88)
-7%
(85)
+4%
EPS (Diluted)
-0.42
N/A
-0.49
-17%
-0.64
-31%
-0.81
-27%
-0.99
-22%
-1.27
-28%
-1.52
-20%
-1.82
-20%
-2.1
-15%
-2.3
-10%
-2.54
-10%
-2.53
+0%
-2.87
-13%
-2.95
-3%
-3.05
-3%
-2.93
+4%

See Also

Discover More